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A B S T R A C T
Large-scale population studies have proved that genetic factors contribute to individual differences in
smoking behavior. Genes responsible for nicotine’s pharmacokinetics and pharmacodynamics seem
mainly involved, although a significant fraction of variance remains unexplained. In this study we
examined 10 SNPs from 8 candidate genes with positive previous reports of association with smoking. A
total of 454 Italian unrelated subjects were genotyped by a multiplex minisequencing assay through the
SNaPShot kit. Cases were chosen as current and former nicotine dependent (FTND  4 and SQ  15),
while controls were smoking-exposed but non-dependent and never smoker individuals (FTND = 0 and
SQ  10 and FTND = 0 and SQ = 0, respectively). Preliminary results shows that the SNPs CHRNA5-
rs16969968 and CHRNA3-rs1051730 could be associated with risk of developing nicotine dependence.
Factors as age, sex, and exposition to smoke were also found as possible factors of risk of nicotine
addiction. The identification of susceptibility loci for individual response to substance abuse is
particularly motivating for medicine for the global epidemic dimension of addictions and the urgent need
of effective preventive and therapeutic strategies.
 2011 Elsevier Ireland Ltd. All rights reserved.
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Substance abuse disorders represent a significant burden on
worldwide health care system and not least permeating each
branch of forensic medicine. Among these, cigarette smoking has a
deleterious impact on society being one of the largest cause of
morbidity and premature deaths in western countries. Despite this
awareness, about 22% of the world population currently consumes
tobacco [1]. Smoking behavior is a complex trait which involves
key behavioral steps from the initial use to a chronic dependence
condition, each of which is influenced by the interplay between
environmental factors and a documented genetic background.
Recent advances in the field through association studies and GWAS
approaches attributed the strongest genetic influence to the
nicotinic acetylcholine receptors and metabolizing genes, making
promising candidates as predictive markers [2]. Even with
considerable progress, a significant fraction of the estimated
heritability (40–60%) as well as the biological mechanism
underlying the correlation with the disease remain unexplained* Corresponding author.
E-mail address: gianmarco.ferri@unimore.it (G. Ferri).
1875-1768/$ – see front matter  2011 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.fsigss.2011.09.106with a plausible involvement of several chromosome regions
throughout the genome [2].
2. Materials and methods
The study population consisted of 454 unrelated volunteers of
Italian origin who have been measured for the degree of nicotine
dependence (ND) with the Fagerström Test for Nicotine Depen-
dence (FTND) (scores 0–10) and for the Smoking Quantity (SQ) per
day. We considered as cases those subjects who show nicotine
dependence (ND) according to FTND and SQ values (FTND  4 and
SQ  15 cigarettes/day), which were classified as current (exposed)
and former (non-exposed) smokers. Controls were those individu-
als displaying not nicotine dependence, sorted as: exposed to
tobacco (FTND = 0 and SQ  10 cigarettes/day) and not exposed
(FTND = 0 and SQ = 0). Genomic DNA was extracted from buccal
swabs using standard Chelex method. A set of 10 autosomal SNPs
(rs2273504, rs806368, rs2023239, rs806380, rs324420,
rs2184026, rs16969968, rs1051730, rs4950, rs686) linked to
different brain systems (CHRN4, CNR1, FAAH, GABAB2, CHRNA5,
CHRNA3, CHRNB3, DRD1) was chosen based on positive previous
reports of association with smoking [3] or other drugs types [4].
SNPs were included in a multiplex PCR using Qiagen Multiplex kit.
Single base extension (SBE) reaction was accomplished by
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electrophoresis on ABI PRISM3130 HID Genetic Analyzer. Frag-
ments were analyzed with GeneMapper ID v 3.2 software. The
descriptive analysis, genotype frequencies, the assessing of
deviations from Hardy–Weinberg equilibrium and the linkage
disequilibrium test were performed with both R project (v2.12.2)
and SNPassoc package, which is at the same time implemented in
R. To identify the potential confounding variables, a bivariate
analysis was carried out. Those variables with a p-value 0.2 were
considered in the multivariate analysis. The independent variables
with the highest level of statistical significance were successively
eliminated from the original model, following the AIC criterion and
using the glm R package.
3. Results
Main results of the descriptive analysis showed that the mean
ages were 37.5 (10.5) years in cases and 30.9 (8.6) in controls.
Likewise, 60.3% of the cases were men, while men in controls were
40.5%. Deviations from HW expectations were found in three SNPs,
DRD1 in cases, CNR1-rs806380 in controls and CNR1-rs2023239 in
both groups (p-values <0.005); however, further analysis are needed
to make reliable conclusions about the observed deviations.
Moreover, p-values from LD test were significant for the majority
of the SNPs pairs (p-value <0.0001), being GABAB2-CNR1 the only
pair with a not significant p-value (>0.165). Anyway, as it was
mentioned above, conclusions must be made after additional analysis
will be performed. Preliminary results from the multivariate model
reveals that the SNPs rs2023239, rs16969968 and rs1051730, located
in the genes CNR1, CHRNA5 and CHRNA3, respectively, could be
associated with risk of developing nicotine dependence. Factors as
age, sex, and exposition to smoke were also found as possible risk
factors for developing nicotine addiction. However, CNR1-rs2023239
show significant deviations from HWE expectations both in the cases
sample and also in controls, therefore this latter result was deemed
unusable for now.
4. Discussion
Psychopharmacological effects of nicotine are mediated pri-
marily by nicotinic cholinergic receptors (nAChRs). Genes encod-
ing subunits have been proposed as plausible candidates for ND
and several have been investigated [2].
Large scale GWAS meta-analyses established association with
CHRNA5–CHRNA3–CHRNB4 gene cluster (chromosome 15q24-
25.1) with smoking severity, dependence and lung cancer.
Specifically, the non-synonymous SNP CHRNA5-rs16969968
and SNP CHRNA3-rs1051730 are the most appealing candidates.Furthermore, rs1051730 is already part of the so-called ‘‘personal
genomics’’ through a direct-to-consumer testing powered by an
Icelandic company to learn your own risk for developing ND [5],
even if the predictive ability is still limited. In line with the
literature, in our population the group of cases (FTND  4) was
more likely to hold the rs16969968-A allele and rs1051730-T allele
comparing with the control group without dependence (FTND = 0).
For both markers the risk alleles were the same as previously
reported [5]. The other analyzed variants did not show significant
differences in frequency distributions. This could also indicate
insufficient statistical power to detect small effects of single
polymorphisms in our sample.
The knowledge of molecular components of complex traits such
as response to drugs, addictive disorders, personality and
phenotypic traits are also entering into the sensitive forensic field
[6]. Current expectations concerning rapid advances in the
neurobiological basis of relevant behaviors are accompanied by
a heated discussion on implication for social institutions and the
justice system [7,8]. Identification of genetic factors affecting
substance dependencies is a major interest of medicine today in
assessing individual vulnerability and in developing more effective
interventions, though multifactorial etiology of addictions needs to
invoke the use of great caution within risk inference.
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